NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial. (Q46028265)
Jump to navigation
Jump to search
scientific article published on 4 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial. |
scientific article published on 4 May 2009 |
Statements
1 reference
NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial. (English)
1 reference
Kjell-Morten Myhr
1 reference
Anders Svenningsson
1 reference
Per Soelberg Sorensen
1 reference
Svein Ivar Mellgren
1 reference
Lise Vejby Søgaard
1 reference
Irina Elovaara
1 reference
Jette Lautrup Frederiksen
1 reference
Antonie Giaever Beiske
1 reference
Inge Christoffer Olsen
1 reference
Magnhild Sandberg-Wollheim
1 reference
4 May 2009
1 reference
1 reference
8
1 reference
6
1 reference
519-529
1 reference